Insider Trading activities at Icagen Inc (ICGN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Icagen Inc (ICGN) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Icagen Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 902622.

Total stock buying since 2010: $49,620,644.
Total stock sales since 2010: $672.
Total stock option exercises since 2010: $116,652.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


11 insiders reported insider trading activities at Icagen Inc (ICGN):
Insider trading activities of Lampert Mark N
Insider trading activities of Sanders Charles A
Insider trading activities of Eclipse Acquisition Corp.
Insider trading activities of Evnin Anthony B
Insider trading activities of Lamotte Andre
Insider trading activities of Katz Richard D
Insider trading activities of Simonetti Martin A
Insider trading activities of Olukotun Adeoye Y
Insider trading activities of Pfizer Inc
Insider trading activities of Morrison Richard G
Insider trading activities of Wagoner Kay

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Icagen Inc (ICGN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2011 8,268,473 $49,611,344 113 $672 42,910 $116,652
2010 25,000 $9,300 0 $0 0 $0

Table 2. Monthly summary of insider trading at Icagen Inc (ICGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-10 2,743,269 $16,459,614 0 $0 0 $0
2011-09 5,525,204 $33,151,730 0 $0 42,910 $116,652
2011-08 0 $0 113 $672 0 $0
2010-08 25,000 $9,300 0 $0 0 $0

Table 3. Detailed insider trading at Icagen Inc (ICGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-10-27 Eclipse Acquisition Corp. (10% Owner) Buy 2,743,269 6.00 16,459,614
2011-09-19 Eclipse Acquisition Corp. (10% Owner) Buy 61,083 6.00 366,498
2011-09-16 Eclipse Acquisition Corp. (10% Owner) Buy 5,536 6.00 33,216
2011-09-15 Eclipse Acquisition Corp. (10% Owner) Buy 232,203 6.00 1,393,218
2011-09-12 Eclipse Acquisition Corp. (10% Owner) Buy 422,023 6.00 2,532,138
2011-09-09 Eclipse Acquisition Corp. (10% Owner) Buy 60,121 6.00 360,726
2011-09-08 Eclipse Acquisition Corp. (10% Owner) Buy 493 6.00 2,958
2011-09-07 Lampert Mark N Buy 126,700 6.00 760,706
2011-09-02 Simonetti Martin A (Director) Option Ex 4,500 3.33 14,998
2011-09-02 Olukotun Adeoye Y (Director) Option Ex 4,500 3.33 14,998
2011-09-02 Evnin Anthony B (Director) Option Ex 7,910 .00 0
2011-09-02 Pfizer Inc (10% Owner) Buy 4,617,045 6.00 27,702,270
2011-09-01 Evnin Anthony B (Director) Option Ex 5,500 3.33 18,331
2011-09-01 Morrison Richard G (Director) Option Ex 4,500 3.33 14,998
2011-09-01 Lamotte Andre (Director) Option Ex 4,500 3.33 14,998
2011-09-01 Sanders Charles A (Director) Option Ex 11,500 3.33 38,329
2011-08-18 Katz Richard D (Ex VP, Fin & Corp, CFO & Treas) Sale 8 5.96 47
2011-08-10 Katz Richard D (Ex VP, Fin & Corp, CFO & Treas) Sale 36 5.96 214
2011-08-10 Wagoner Kay (President and CEO) Sale 69 5.96 411
2010-08-17 Wagoner Kay (President and CEO) Buy 25,000 .37 9,300

Insider trading activities including stock purchases, stock sales, and option exercises of ICGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Icagen Inc (symbol ICGN, CIK number 902622) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.